← Back
Data updated: Mar 10, 2026
RANBAXY LABS LTD
Infectious DiseaseGastroenterologyDermatology
RANBAXY LABS LTD is a generic drug manufacturer focused on Infectious Disease, Gastroenterology, Dermatology. Key products include SERTRALINE HYDROCHLORIDE.
1964
Since
41
Drugs
-
Trials
546
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
GABAPENTIN 2026-02-24
Labeling
DOXYCYCLINE HYCLATE 2026-02-19
GABAPENTIN 2026-02-18
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-12
Labeling
PRAVASTATIN SODIUM 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
GABAPENTIN 2026-01-29
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 36%
4 drugs
Gastroenterology 18%
2 drugs
Dermatology 18%
2 drugs
Immunology 18%
2 drugs
Respiratory 9%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Infectious Disease, Dermatology, Immunology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Gastroenterology, Respiratory
PHARMACIA AND UPJOHN big-pharma
Dermatology, Infectious Disease, Respiratory, Immunology
Gilead Sciences biotech
Infectious Disease, Immunology, Gastroenterology, Respiratory
MALLINCKRODT specialty
Gastroenterology, Dermatology, Immunology, Respiratory
Active (14)
Discontinued (25)
GABAPENTIN HYDROCODONE BITARTRATE AND ACETAMINOPHEN FLUCONAZOLE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF METFORMIN HYDROCHLORIDE RISPERIDONE RIVASTIGMINE ZIDOVUDINE CEFPROZIL NEVIRAPINE TERAZOSIN HYDROCHLORIDE GLIMEPIRIDE GALANTAMINE HYDROBROMIDE FEXOFENADINE HYDROCHLORIDE CEFACLOR RIOMET CEFADROXIL FOSINOPRIL SODIUM AVENTYL CARBILEV RANICLOR DISPERMOX PANIXINE DISPERDOSE GANCICLOVIR
Company Info
- First Approval
- 1964-11-06
- Latest
- 2018-11-06
- Applications
- 53
FDA Sponsor Names
RANBAXY LABS LTDRANBAXY